Our qRT-PCR results indicated that Odo A treatment led to upregulation of CASP3, CASP7, CASP8, and CASP9 expression, which suggests that the extrinsic route was responsible for blocking the development of lung cancer cells (Figure 2A). This evidence concerns the gene CASP7 and lung cancer.